Skip to content
healthcare.dev

Omvoh

NDC 0002-8870, mirikizumab-mrkz, injection, solution, from Eli Lilly and Company.

Product NDC
0002-8870
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761279
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8870 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRIKIZUMAB100 mg/mL

Pharmacologic classes

Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
0002-8870-27000028870272 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/472cbe04-263e-433d-9a0f-58c1b50b715a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0002-8870

Use it

Look up 0002-8870 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8870 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-8870. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.